The immune system of patients infected by SARS-CoV-2 is severely impaired. Detailed
investigation of T cells and cytokine production in patients affected by COVID-19 pneumonia are …

Background Patients with COVID-19 experience multiple clinical conditions that may cause
electrolyte imbalances. Hypokalemia is a concerning electrolyte disorder closely associated …

Aims The aim of this study was to estimate a 48 hour prediction of moderate to severe
respiratory failure, requiring mechanical ventilation, in hospitalized patients with COVID-19 …

SIR, Thrombosis in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection represents the most relevant extra-pulmonary manifestation of COVID-19 and …

Objectives Sex differences in COVID-19 severity and mortality have been described. Key
aims of this analysis were to compare the risk of invasive mechanical ventilation (IMV) and …

Background: Treatment guidelines recommend the tocilizumab use in patients with a CRP
of >7.5 mg/dL. We aimed to estimate the causal effect of glucocorticoids + tocilizumab on …

The immunological mechanisms that modulate immune response to SARS‐CoV‐2 infection
remain elusive. Little is known on the magnitude and the durability of antibody response …

The objective of this study was to characterize frailty and resilience in people evaluated for
Post-Acute COVID-19 Syndrome (PACS), in relation to quality of life (QoL) and Intrinsic …

Background The benefit of tocilizumab on mortality and time to recovery in people with severe
COVID pneumonia may depend on appropriate timing. The objective was to estimate the …

The aim of this study was to evaluate both positive outcomes, including reduction of respiratory
support aid and duration of hospital stay, and negative ones, including mortality and a …